Invitrogen™ Lipofectamine™ CRISPRMAX™ Cas9 Transfection Reagent

The first optimized lipid nanoparticle transfection reagent for CRISPR-Cas9 protein delivery.

Supplier:  Invitrogen™ CMAX00008

Catalog No. CMAX00008

Description

• Demonstrated cleavage efficiency—tested in over 20 cell types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others
• Low cell toxicity—less cells needed to initiate your experiment
• High throughput friendly—an ideal delivery solution for 96-well format
• Lipofectamine CRISPRMAX transfection reagent increases the likelihood of successful cleavage and recombination, especially when combined with our TrueCut Cas9 Protein v2 and TrueGuide Synthetic gRNA.
• Unlike CRISPR plasmid or Cas9 mRNA, using Cas9 protein provides superior cleavage efficiency in primary cells and stem cells.
• It eliminates the need for transcription or translation of the payload, removes the risk of genomic integration, and is cell cycle independent.

Specifications

• Classification: Animal Origin-Free
• Cell Type: Established Cell Lines, Stem Cells, Primary Cells, Hard-to-Transfect Cells
• Sample Type: Protein, Ribonucleoprotein, Cas9 Ribonucleoprotein, Cas9, Plasmid DNA
• For Use With (Application): Transfection
• Product Type: Transfection Reagent
• Serum Compatible: Yes

• Content And Storage: Contains one vial of Lipofectamine CRISPRMAX Reagent and one vial of Cas9 Plus Reagent.
  
  Store at 2–8°C. Do not freeze.
• Format: 6-well Plate, 12-well Plate, 24-well Plate, 48-well Plate, 96-well Plate, Flasks
• Transfection Technique: Lipid-based Transfection
• Product Line: CRISPRMAX™, Lipofectamine™
• Quantity: 0.75 mL
• Shipping Condition: Approved for shipment on Wet Ice

For Research Use Only. Not for use in diagnostic procedures.